ESSA Pharma Inc
(TSX Venture Exchange : EPIX)

( )
EPIX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
2.27%43.780.9%$859.90m
JNJJohnson & Johnson
0.08%133.860.6%$796.43m
MRKMerck & Co., Inc.
2.05%69.770.6%$563.93m
LLYEli Lilly and Company
2.38%110.481.0%$502.61m
ABBVAbbVie, Inc.
0.99%90.632.2%$478.78m
BMYBristol-Myers Squibb Company
-0.04%57.481.4%$328.51m
NVSNovartis AG Sponsored ADR
0.83%83.460.2%$164.39m
AZNAstraZeneca PLC Sponsored ADR
0.78%37.431.3%$137.85m
NVONovo Nordisk A/S Sponsored ADR Class B
-1.15%42.040.1%$79.09m
GSKGlaxoSmithKline plc Sponsored ADR
0.47%38.490.2%$78.44m
SNYSanofi Sponsored ADR
1.24%43.440.2%$57.28m
LCILannett Company, Inc.
3.07%4.0337.0%$6.64m
AKTXAkari Therapeutics Plc Sponsored ADR
-9.50%1.811.7%$0.15m

Company Profile

ESSA Pharma, Inc. is a pharmaceutical company. It engages in the development of small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.